Advertisement
Canada markets closed
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7297
    -0.0024 (-0.32%)
     
  • CRUDE OIL

    82.84
    +0.03 (+0.04%)
     
  • Bitcoin CAD

    87,837.91
    -3,238.28 (-3.56%)
     
  • CMC Crypto 200

    1,390.87
    -33.23 (-2.33%)
     
  • GOLD FUTURES

    2,330.60
    -7.80 (-0.33%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,470.25
    -194.25 (-1.10%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6819
    -0.0017 (-0.25%)
     

Is This the Telltale Sign to Sell Novavax Stock?

Is This the Telltale Sign to Sell Novavax Stock?

Unfortunately, Novavax (NASDAQ: NVAX) hasn't had great timing. The company was late to the party in winning authorizations for its COVID-19 vaccine, Nuvaxovid. If you only looked at Novavax's press releases, you wouldn't know about some recent bad news for the company.